Emotra is a research and development based medical device company, situated in Gothenburg, Sweden. We develop, clinically document and market our unique objective and quantitative method/product EDOR® for testing depressed patients within the psychiatric care.

A series of clinical studies have proven that the test identifies hyporeactive individuals and that these are more vulnerable for suicide actions than others.

The Emotra AB:s share has been listed on Spotlight Stock Market since 28/06/2013 under the ticker EMOT and is traded through banks and stockbrokers.